Literature DB >> 2389569

[Comparative evaluation of the antiviral efficacy of virazole and ribamidil in experimental Lassa fever in monkeys].

V I Dvoretskaia, A A Evseev, G V Bogatikov, V A Pshenichnov.   

Abstract

Lassa virus administered to monkeys aerogenically induced in these laboratory animals a fatal disease modelling the severe course of human Lassa fever. It was demonstrated experimentally that ribamydil, a Soviet analogue of virasol, as well as foreign commercial virasol was therapeutically effective in experimental Lassa fever in aerogenically infected monkeys.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2389569

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN： 0507-4088


  2 in total

1.  Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Authors:  Alex P Salam; Alexandre Duvignaud; Marie Jaspard; Denis Malvy; Miles Carroll; Joel Tarning; Piero L Olliaro; Peter W Horby
Journal:  PLoS Negl Trop Dis       Date:  2022-03-30

2.  Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria.

Authors:  Cyril Erameh; Osahogie Edeawe; Peter Akhideno; Gloria Eifediyi; Till F Omansen; Christine Wagner; Francisca Sarpong; Till Koch; Sebastian Wicha; Florian Kurth; Sophie Duraffour; Lisa Oestereich; Meike Pahlmann; Sylvanus Okogbenin; Ephraim Ogbaini-Emovon; Stephan Günther; Michael Ramharter; Mirjam Groger
Journal:  BMJ Open       Date:  2020-04-16       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.